From: Appendix E, Genetic Toxicology
This is a work of the US government and distributed under the terms of the Public Domain
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Strain | Concentration (μg/plate) | Without S9 | With 10% Rat S9 |
---|---|---|---|
TA98 | |||
0 | 15 ± 1 | 43 ± 3 | |
33 | 13 ± 2 | 25 ± 2 | |
100 | 19 ± 1 | 33 ± 2 | |
333 | 19 ± 1 | 38 ± 1 | |
1,000 | 16 ± 2 | 31 ± 3 | |
3,333 | 14 ± 1 | 34 ± 3 | |
Trial Summary | Negative | Negative | |
Positive Controlb | 97 ± 4 | 594 ± 29 | |
TA100 | |||
0 | 126 ± 9 | 147 ± 2 | |
33 | 149 ± 3 | 139 ± 5 | |
100 | 141 ± 6 | 148 ± 5 | |
333 | 137 ± 1 | 136 ± 5 | |
1,000 | 133 ± 5 | 108 ± 4 | |
3,333 | 51 ± 14 | 74 ± 21 | |
Trial Summary | Negative | Negative | |
Positive Controlc | 434 ± 21 | 929 ± 43 | |
TA102 | |||
0 | 286 ± 14 | 384 ± 15 | |
34 | 288 ± 4 | 389 ± 18 | |
102 | 299 ± 8 | 386 ± 12 | |
340 | 304 ± 11 | 397 ± 19 | |
1,019 | 272 ± 29 | 365 ± 43 | |
3,333 | 132 ± 17 | 180 ± 21 | |
Trial Summary | Negative | Negative | |
Positive Controld | 930 ± 64 | 1,310 ± 22 |
Studies performed at BioReliance. Data are presented as revertants/plate (mean ± standard error) from three plates; 0 μg/plate served as the solvent control.
The positive control in the absence of metabolic activation was 4-nitro-o-phenylenediamine (1.0 μg/plate); the positive control for metabolic activation was 2-aminoanthracene (0.4 μg/plate).
The positive control in the absence of metabolic activation was sodium azide (0.5 μg/plate); the positive control for metabolic activation was 2-aminoanthracene (0.75 μg/plate).
The positive control in the absence of metabolic activation was mitomycin C (75.0 μg/plate); the positive control for metabolic activation was sterigmatocystin (10.0 μg/plate).
From: Appendix E, Genetic Toxicology
This is a work of the US government and distributed under the terms of the Public Domain
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.